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the	physiological	 decidual–myometrial	 junction	 zone.2,3	The	 current	
prevailing	hypothesis	 is	 that	 a	 defect	 of	 the	 endometrium–myome-
trial	 interface,	typically	at	the	site	of	a	prior	hysterotomy,	leads	to	a	
failure	 of	 normal	 decidualization	 in	 the	 corresponding	 uterine	 area.	
This	 allows	 extravillous	 trophoblastic	 infiltration	 and	 villous	 tissue	







trium,	 three	 subtypes	 have	 been	 differentiated	 by	 pathologists:	 (1)	
superficial	placenta	accreta	(also	called	placenta	creta,	vera,	or	adher-
enta),	where	the	villi	attach	directly	to	the	surface	of	the	myometrium	
without	 invading	 it;	 (2)	 placenta	 increta,	 where	 the	 villi	 penetrate	
deeply	into	the	myometrium	up	to	the	external	layer;	and	(3)	placenta	







of	 abnormally	 adherent	 and	 invasive	 placentation	 in	women	with	 a	
prior	cesarean	delivery	supports	the	latter	concept.3
The	 challenge	 in	 writing	 this	 chapter	 on	 the	 epidemiology	 of	
accreta	placentation	was	the	heterogeneous	definition	of	the	condi-
tion.	Nearly	half	of	 the	cohort	 studies	published	over	 the	 last	 three	
decades	 do	 not	 provide	 evidence	 of	 correlation	 between	 prenatal	
ultrasound	signs,	clinical	symptoms,	and	detailed	pathologic	findings	
at	 delivery.5	 In	 addition,	 the	 recent	 inclusion	 of	 both	 adherent	 and	
invasive	 forms	of	accreta	placentation	 into	one	archaic	category	 i.e.	
“morbidly	 adherent”	 makes	 the	 interpretation	 of	 clinical	 data	 more	






Massive	 obstetric	 hemorrhage	 is	 one	 of	 the	 most	 severe	 mor-
bidities	of	 childbirth	and	one	of	 the	most	 important	and	potentially	
avoidable	 causes	 of	 maternal	 death.	 Retained	 placental	 tissue	 and	
secondary	uterine	atony	remains	one	of	the	most	common	causes	of	
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massive	obstetric	hemorrhage	globally,	and	postpartum	hemorrhage	
in	particular.9	Any	attempt	 to	manually	 remove	a	PAS	disorder	 typi-






















2  | UTERINE SCAR AND 
ACCRETA PLACENTATION
Theoretically,	any	primary	uterine	anomaly	or	secondary	damage	to	









































1 At cesarean or vaginal delivery:	Complete	placental	separation	at	third	stage.	Normal	adherence	of	placenta
2 (A)  Cesarean/laparotomy:	No	placental	tissue	seen	invading	through	the	surface	of	the	uterus.	Incomplete	separation	with	uterotonics	and	
gentle	cord	traction,	and	manual	removal	of	placenta	required	for	remaining	tissue	and	parts	of	placenta	thought	to	be	abnormally	adherent
(B) Vaginal delivery:	Manual	removal	of	placenta	required	and	parts	of	placenta	thought	to	be	abnormally	adherent

















transfusion	were	 included	 the	 rate	was	4.6	per	10	000	deliveries.8,27 
A	 recent	 meta-	analysis	 of	 five	 cohorts	 and	 11	 case–control	 studies	
reported	a	summary	OR	of	1.96	(95%	CI	1.41–2.74)	for	PAS	disorders	
after	a	cesarean	delivery.26	The	corresponding	data	were	not	stratified	




and	 to	55.9	 (95%	CI	25.0–110.3)	 after	 three	or	more	prior	 cesarean	
deliveries.8,9,15	A	multicenter	study	of	30	132	women	who	underwent	
elective	cesarean	delivery	(without	prior	labor)	in	19	academic	hospitals	
in	 the	USA	between	1999	and	2002	 found	 that	143	had	PAS	disor-
ders	and	that	the	risk	increased	from	0.24%	after	one	prior	cesarean	to	
6.74%	after	six	or	more	previous	cesarean	deliveries.16
A	 decision-	analytic	 model	 built	 using	 data	 on	 national	 birthing	
order	 trends	 after	 cesarean	 delivery	 in	 the	USA	between	1995	 and	
2005	estimated	that	 if	 the	number	of	primary	and	secondary	cesar-
eans	 continues	 to	 rise,	 by	 2020	 the	 cesarean	 delivery	 rate	 will	 be	
56.2%	and	that,	as	a	consequence,	 there	will	be	an	additional	6236	






dataset.23	Overall,	 the	 study	 found	 that	 the	unadjusted	 rate	of	PAS	
disorders	increased	by	30.8%	among	women	with	a	repeat	cesarean	
delivery.	 Compared	 with	 women	 with	 a	 primary	 cesarean	 delivery,	
women	who	underwent	a	repeat	cesarean	were	2.13	times	more	likely	
to	have	PAS	disorders	(95%	CI	1.98–2.29).
2.2 | Other etiologies of accreta placentation
PAS	disorders	are	not	exclusively	a	consequence	of	cesarean	deliv-
ery.29	 Procedures	 causing	 less	 surgical	 damage	 to	 the	 integrity	 of	





with	 no	 prior	 uterine	 surgery,	 but	 with	 uterine	 pathology	 such	 as	
bicornuate	 uterus,	 adenomyosis,	 submucous	 fibroids,	 and	 myotonic	
















case–control	 cohort	 study15	 and	 retrospective	 cohort	 study.21	 This	
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compared	with	 0.12%	 in	 spontaneous	 pregnancies	 (OR	 13.2,	 95%	CI	















products	 of	 conception	 in	 around	 one-	third	 of	 surgical	 terminations	
and	uterine	curettages	for	miscarriage.34	Myometrial	fibers	have	also	
been	noted	 in	the	basal	plate	 in	placenta	from	previous	deliveries	 in	
women	presenting	with	PAS	disorders	and	greater	quantities	of	myo-
metrial	fibers	 in	 a	delivered	placenta	have	been	associated	with	 the	










3  | PLACENTA PREVIA ACCRETA AND 
CESAREAN SCAR PREGNANCY































The	 UKOSS	 study	 found	 that	 the	 incidence	 of	 PAS	 disorders	
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a	 previous	 cesarean	 delivery	 and	 placenta	 previa.17	 The	 estimated	
ORs	of	PAS	disorders	in	cases	of	placenta	previa	diagnosed	prenatally	
range	between	51.4	(95%	CI	10.6–248)15	and	614	(95%	CI	372–844)8 


















































scar	pregnancy	diagnosed	 in	 the	first-	trimester,	which	 subsequently	
developed	 into	 placenta	 previa	 accreta,	 there	 has	 been	 mounting	












ogy,	 and	 thus,	 in	 case	 of	 successful	 conservative	management,	 it	 is	
difficult	to	be	certain	that	a	scar	pregnancy	is	truly	accreta.
4  | DEPTH OF VILLOUS INVASION 


































0 6201 15	(0.24%) 3% 40	(0.65%)
1 15 808 49	(0.31%) 11% 67	(0.42%)
2 6324 36	(0.57%) 40% 57	(0.9%)
3 1452 31	(2.13%) 61% 35	(2.4%)
4 258 6	(2.33%) 67% 9	(3.49%)
5 89 6	(6.74%) 67% 9	(8.99%)
aModified	from	Silver	et	al.16
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containing	 PAS	 disorders.	 Previous	 studies	 have	 indicated	 that	 PAS	
disorders	can	be	focal	or	partial	and	heterogeneous,	mixing	adherent	
and	 invasive	 accreta	 villous	 tissue.55–58	 In	 addition,	 the	 histopatho-
logic	diagnosis	of	PAS	disorders	 can	be	very	difficult	 if	 the	 surgeon	
has	attempted	to	remove	the	placenta	during	delivery	or	impossible	in	
cases	of	conservative	management	with	the	placenta	left	in	situ.









the	 depth	 of	 villous	 invasion	 and	 the	 number	 of	 previous	 cesarean	
deliveries.	They	noted	five	placenta	 creta,	 one	placenta	 increta,	 and	
two	placenta	previa	after	one	cesarean	delivery;	seven	placenta	creta,	
seven	 placenta	 increta,	 and	 11	 placenta	 previa	 after	 two	 cesarean	


















tested	 prospectively	 but	 it	 provides	 a	 good	 starting	 point	 for	 further	
prospective	 epidemiologic	 studies.	Ultrasound	 imaging	 is	 a	 promising	
screening	 tool	 for	PAS	disorders44	 and	a	combination	of	well-	defined	
ultrasound	features	and	standardized	clinical	criteria	with	detailed	histo-
pathologic	correlation	should	also	be	used	in	future		clinical	research.3,5,71
5  | THE IMPACT OF 
SURGICAL TECHNIQUES
It	 has	 been	 suggested	 that	 surgical	 techniques	 used	 for	 entering	 and	
closing	 the	 uterus	 during	 cesarean	 delivery	 could	 play	 a	 role	 in	 the	
etiology	of	PAS	disorders.12	 For	 example,	 single-	layer	 uterine	 closure	
versus	 a	multiple	 overlapping	 layer	 type	 of	 closure,	 or	 locked	 versus	
interrupted	 suturing,	 or	different	 suture	materials	 could	 influence	 the	










Author (year) Total no. of cases
No. of placenta  
creta
No. of placenta 
increta
No. of placenta 
percreta
Luke	et	al.55	(1966) 21 14 7 0
Weekes	et	al.56	(1972) 7 6 0 1
Breen	et	al.57	(1977) 40 31 7 2
Morison	et	al.58	(1978) 50 31 14 5
Total	case	series	(%) 118 82	(69.5%) 28	(23.7%) 8	(6.8%)
Twickler	et	al.59	(2000) 9 3 2 4
Comstock	et	al.60	(2004) 15 8 3 4
Woodring	et	al.61	(2011) 10 8 1 1
Lim	et	al.62	(2011) 9 5 3 1
Cali	et	al.63	(2013) 41 15 9 17
Maher	et	al.64	(2013) 42 28 13 1
Riteau	et	al.65	(2014) 26 16 0 10
Algebally	et	al.66	(2014) 32 16 12 4
Satija	et	al.67	(2015) 10 3 4 3
Kumar	et	al.68	(2016) 9 1 2 6
Total	cohorts	with	a	prenatal	diagnosis	(%) 203 103	(50.7%) 49	(24.2%) 51	(25.1%)
     |  271Jauniaux ET aL.
similar	incidence	of	uterine	scar	defects	in	women	who	had	a	single-	layer	
compared	 with	 double-	layer	 closure	 (RR	 0.77,	 95%	 CI	 0.36–1.64).73 
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